| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 20610 |
|
1,319 |
554 |
$49K |
| 77002 |
|
1,960 |
867 |
$40K |
| 73580 |
|
757 |
428 |
$34K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
484 |
223 |
$34K |
| 76881 |
|
691 |
467 |
$32K |
| 27369 |
|
1,207 |
519 |
$31K |
| J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
593 |
215 |
$23K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,494 |
761 |
$12K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
721 |
348 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
494 |
375 |
$10K |
| 73560 |
|
408 |
305 |
$6K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
308 |
149 |
$5K |
| 97161 |
|
201 |
161 |
$5K |
| 73564 |
|
199 |
98 |
$4K |
| J7328 |
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg |
24 |
12 |
$3K |
| 20611 |
|
66 |
54 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,482 |
691 |
$700.72 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
78 |
56 |
$649.18 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
61 |
37 |
$615.26 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
363 |
226 |
$566.94 |
| 97535 |
Self-care/home management training, each 15 minutes |
50 |
41 |
$522.20 |
| 97116 |
|
31 |
16 |
$112.23 |
| G2064 |
Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities |
58 |
51 |
$48.79 |